Business Combinations, Asset Acquisitions, and Goodwill (Tables)

12 Months Ended

Dec. 31, 2024

Business Combination and Asset Acquisition [Abstract]

Schedule of Business Acquisitions, by Acquisition

The following table summarizes the purchase price allocation of the fair value of assets acquired and liabilities assumed related to each acquisition at the acquisition date for acquisitions that closed during the year ended December 31, 2024 (in thousands):

	CHS			AHMS			CFC		Others*		Net Total
Total purchase consideration:
Cash paid	$	35,322		$	63,935		$	90,998	$	15,000	$	205,255
Purchase price due to (from) seller		6,944			(2,995	)		—		—		3,949
Contingent consideration		5,154			—			8,026		6,161		19,341
Common stock issued and replacement awards		118			—			21,952		—		22,070
Conversion of promissory note					—			—		5,175		5,175
	$	47,538		$	60,940		$	120,976	$	26,336	$	255,790
Assets:
Cash and cash equivalents	$	4,556		$	33,950		$	16,674	$	3,515	$	58,695
Investment in marketable securities		—			—			—		30		30
Receivables		87,416			11,007			6,530		—		104,953
Other receivables		54,194			—			472		—		54,666
Prepaid expenses and other current assets		357			36			2,902		11		3,306
Property and equipment, net		—			—			—		823		823
Intangible assets		14,200			23,600			28,000		6,338		72,138
Goodwill		12,151			25,731			83,571		16,357		137,810
Income tax receivable		—			—			—		1		1
Investments in other entities – equity method		3,125			—			—		—		3,125
Restricted cash		—			300			—		—		300
Total assets acquired	$	175,999		$	94,624		$	138,149	$	27,075	$	435,847
Liabilities:
Accounts payable and accrued expenses	$	68,115		$	13,001		$	2,486	$	303	$	83,905
Medical liabilities		60,424			14,253			14,663		—		89,340
Income taxes payable		—			—			24		—		24
Deferred tax liability		—			6,430			—		8		6,438
Non-controlling interest		(78	)		—			—		428		350
Total liabilities assumed	$	128,461		$	33,684		$	17,173	$	739	$	180,057
Total net assets acquired	$	47,538		$	60,940		$	120,976	$	26,336	$	255,790

*Others consist of estimated fair values of the assets acquired, net of cash acquired, related to ADSC, PCCCV, Airline Complete, and DWGAS.

Unaudited Pro Forma Financial Information

The pro forma financial information in the table below presents the combined results of the Company and the acquisitions in 2024 as if the acquisitions had occurred on January 1, 2023. The pro forma information presented is shown for illustrative purposes only and is not necessarily indicative of future results of operations of the Company or results of operations of the Company that would have actually occurred had the transactions been in effect for the periods presented.

	For the Years Ended December 31,
(in thousands, except per share amounts)	2024		2023
Total revenue	$	2,732,932	$	2,655,460
Net income attributable to Astrana Health, Inc.	$	20,885	$	57,381
Net income per share – basic	$	0.44	$	1.23
Net income per share – diluted	$	0.44	$	1.22

Schedule of Change in Carrying Value of Goodwill

The change in the carrying value of goodwill for the years ended December 31, 2024 and 2023 was as follows (in thousands):

	Amount
Balance at January 1, 2023	$	269,053
Acquisitions		7,866
Adjustments		1,912
Balance at December 31, 2023		278,831
Acquisitions		137,810
Adjustments		2,612
Balance at December 31, 2024	$	419,253